Offstream
news

---

Changes

1. Saudi Arabia approves the vaccine developed by Moderna.
   2021-07-10 01:06:16 (First version)
2. Saudi Arabia approves the COVID-19 vaccine developed by Moderna.
   (Current version)

---

Related

Moderna requests emergency use authorization for its COVID-19 vaccine in babies, toddlers, and young children.
2022-04-28

Moderna says that it will ask the U.S. FDA for approval of their COVID-19 vaccine.
2022-03-23

Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine.
2022-03-10

The United States government purchases 200 million doses of the vaccine produced by Moderna.
2021-06-16

Moderna says that it has requested full approval for its vaccine from the U.S. Food and Drug Administration. Currently, it has only been approved for emergency use.
2021-06-1

Moderna says that their vaccine is 100% effective in teenagers between the ages of 12 and 17. They say that they will seek approval from the U.S. Food and Drug Administration in early June.
2021-05-25

Moderna says its vaccine is 90% effective against COVID-19, and 95% effective against severe disease for six months after the second dose. It also says its vaccine is effective against the 501.V2 variant from South Africa.
2021-04-13

Moderna announces that they will ship their vaccine candidate for testing against the 501.V2 variant that originated in South Africa.
2021-02-24

The European Commission signs a deal with Moderna to secure additional 300 million doses of the vaccine in the European Union.
2021-02-17

The Medicines and Healthcare products Regulatory Agency approves a vaccine made by Moderna for use in the UK. This comes after clinical trials found the vaccine had an efficacy of 94.1% and 100% for severe cases.
2021-01-8